More in Neurology & Neurosurgery

Reuters Health • The Doctor's Channel Daily Newscast

Targeted agents prolong life but don’t cure advanced kidney cancer

NEW YORK (Reuters Health) – In advanced renal cell cancer, targeted inhibitors of the vascular epithelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pathways improve progression-free survival in both first-line and second-line settings. However, these treatments rarely yield complete...

Reuters Health • The Doctor's Channel Daily Newscast

Bayley-III overestimates neurodevelopment in at-risk children

NEW YORK (Reuters Health) – The third edition of the Bayley Scales of Infant and Toddler Development (Bayley-III) overestimates neurodevelopment after early complex cardiac surgery, researchers from Canada report in the September 26th online Pediatrics. Bayley-III, which replaced the older edition of the...

Reuters Health • The Doctor's Channel Daily Newscast

Stereotactic radiosurgery has advantages in treating brain metastases

NEW YORK (Reuters Health) – For patients with a limited number of brain metastases, treatment with stereotactic radiosurgery alone is as good as whole-brain radiotherapy plus stereotactic radiosurgery in terms of overall survival – with less risk of neurocognitive side effects. That’s the conclusion of...

Treating Migraines

Identifying Migraine Headaches

Headaches and Your Health